Brind.

Collegium Pharmaceutical announced upgraded revenue guidance and a buyback program on August 21, leading to market reassessment.

1 report, 1 independent Updated Aug 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Collegium Pharmaceutical announced upgraded revenue guidance and a buyback program on August 21, leading to market reassessment.

Who's involved

What this event is mainly about
Collegium Pharmaceutical (United States)Market

How it developed

Newest first. Tap a step to see who reported it.
  1. Jefferies facilitated a share repurchase agreement for Collegium Pharmaceutical.Sub-event
  2. Collegium Pharmaceutical upgraded its revenue guidance and announced a buyback program, prompting market reassessment.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Collegium Pharmaceutical (COLL): Assessing Valuation Following Q2 Results and Upgraded Full-Year Revenue Guidance Collegium Pharmaceutical (COLL) just released its second-quarter earnings, and the re